Schwab US Dividend Equity ETF Sees Inflows Amid Modest Gains

Schwab US Dividend Equity ETF ( $SCHD ) has risen by 0.40% in the past week. It has experienced a 5-day net inflow of $216.19 million.
This is due, in part, to market sentiment on some of the ETF’s largest holdings. For example:

• Bristol-Myers Squibb Company was not directly covered in the latest technical-analysis driven reports, leaving investors without fresh trading signals or consensus rating updates for the past week. In the absence of new data, market participants may focus on the company’s existing fundamentals, pipeline news, and broader sector moves in large-cap pharmaceuticals when assessing the stock’s near-term prospects.
• Merck & Company likewise did not feature in the recent batch of technical screeners, so there were no newly highlighted momentum signals or Strong Buy/Sell calls tied to short-term price action. Investors watching Merck will therefore need to rely on previously disclosed guidance, drug portfolio developments, and overall healthcare market sentiment to gauge potential stock direction.
• Conocophillips stood out in the latest technical analysis as a bullish name, with TipRanks’ Technical Analysis Screener flagging the stock as a Strong Buy. The shares are described as being in an upward trend, supported by a Strong Buy rating on both overall technical consensus and moving averages, with all 12 tracked indicators flashing bullish signals. This broad-based positive momentum suggests that traders and investors see short- to mid-term upside potential for the energy producer as it continues to benefit from favorable technical conditions in the oil and gas space.